Tiny heart monitor could predict heart failure Flare-Ups

NCT ID NCT06989580

Recruiting now Knowledge-focused Sponsor: Biotronik SE & Co. KG Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study is testing a special heart monitor, the BIOMONITOR IV, in 300 people with heart failure who also have irregular heartbeats. The device tracks heart activity, fluid levels, and breathing patterns to see if it can predict when heart failure gets worse. Researchers hope to develop an early warning system that helps doctors step in sooner and keep patients out of the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BIOMONITOR IV implantable cardiac monitor with study software
What this could lead to: If successful, this could lead to a predictive algorithm that alerts doctors early to worsening heart failure, potentially reducing hospital visits and deaths.
What could go wrong: This is an observational data-collection study, not a treatment trial. The algorithm may not prove accurate enough to change outcomes, and results may not apply to all heart failure patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation cardiac rhythm disease congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIA ATRIAL FIBRILLATION DECOMPENSATED HEART FAILURE HEART FAILURE

Contacts and locations

Locations

Peter Osypka Herzzentrum
NOT_YET_RECRUITING

Munich, Germany
Ziekenhuis Oost Limburg AV
RECRUITING

Genk, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.